Trial intelligence / Profile preview

Withholding vs Routine Hydrocortisone in Pituitary Adenoma Surgery

NCT04621565Unknown

Sponsor
Peking Union Medical College Hospital
Start
Nov 2020
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of hydrocortisone in adrenal insufficiency (AI) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Rate of newly-onset adrenal insufficiency at 3 days. Status: unknown.

02

Drugs

hydrocortisone
03

Conditions

adrenal insufficiency (AI)

Beyond the preview

Go deeper on NCT04621565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04621565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call